SCHEMBL30809567

SCHEMBL30809567

Cc1ncc(NC(=O)OC(C)(C)C)cc1NC(=O)c1cnn2cc(-c3ccc(F)nc3)sc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 1/20 0.34
▸ KIT P10721 1/20 0.34
▸ RORC P51449 3/20 0.33
▸ EGLN2 Q96KS0 2/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ IRAK4 Q9NWZ3 1/20 0.33
▸ PIK3C3 Q8NEB9 1/20 0.32
▸ AR P10275 1/20 0.32
▸ DGAT1 O75907 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ HDAC9 Q9UKV0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30809568 1.00 CSF1R (0.34) CSF1RKITRORCEGLN2GSK3B
SCHEMBL29759653 0.87 CSF1R (0.42) CSF1RKITRORCGSK3BDYRK1A
SCHEMBL24576975 0.87 CSF1R (0.42) CSF1RKITRORCGSK3BDYRK1A
SCHEMBL24577348 0.86 CSF1R (0.34) CSF1RKITRORCEGLN2GSK3B
SCHEMBL30809541 0.85 PDGFRA (0.35) CSF1RKITIRAK4PIK3C3CHRM1
SCHEMBL24577084 0.84 IKBKE (0.37) CSF1RKITGSK3BDYRK1AIRAK4
SCHEMBL24577987 0.84 LCK (0.37) CSF1RKITRORCGSK3BDYRK1A
SCHEMBL29759686 0.83 KIT (0.33) CSF1RKITRORCGSK3BDYRK1A
SCHEMBL24579033 0.83 KIT (0.33) CSF1RKITRORCGSK3BDYRK1A
SCHEMBL30809572 0.83 IKBKE (0.35) IRAK4PIK3C3CHRM1PDGFRAHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247596-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-12-28 — — WO disclosed
Send feedback